Hare
HomeInsights

INDUSTRY:

Pharma

TOPIC:

Regulatory & Legal

TITLE:

NMA: EMA press release on triggering re-evaluation of solutions for infusion containing hydroxyethyl-starch (HES)

BRIEF:

NMA informs that EMA conclusioned from 2 studies that there is a low degree of compliance with restrictions designed to reduce the risk of kidney damage and death on HES usage.

LEGAL IMPLICATIONS:

BUSINESS IMPLICATIONS:

Special Report

In an unexpected move, just before the end of 2011, ...

Case Study

Improving expenditure efficiency has been, for a ver...

Your Portal Link to Mass Media Universe.

Valuable Quarterly Romanian Market Analysis.

Ask the analyst

Tailor-made advice for you

Feature Company